首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Antidiabetic and hypolipidemic activities of hydroethanolic root extract of Uvaria chamae in streptozotocin induced diabetic albino rats
【2h】

Antidiabetic and hypolipidemic activities of hydroethanolic root extract of Uvaria chamae in streptozotocin induced diabetic albino rats

机译:链脲佐菌素诱发的糖尿病白化病大鼠沙门氏菌氢乙醇根提取物的抗糖尿病和降血脂活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDiabetes mellitus is a metabolic disorder of multiple aetiology characterised by hyperglycemia resulting from defects in insulin secretion, insulin action or both. It is a global epidemic ravaging both developed and developing countries. The situation will worsen if nothing is done urgently. In fact, the need to identify natural products with antidiabetic potentials is of great importance as supported by several research efforts all over the world, in search of antidiabetic plant based products that are safe and efficacious. Available literatures show that several phytochemicals with antidiabetic properties have been identified in certain plants amongst which include Uvaria chamae. The potentials of Uvaria chamae as an antidiabetic and hypolipidemic drug-candidate are thus tested.
机译:背景技术糖尿病是一种多种病因的代谢性疾病,其特征在于胰岛素分泌,胰岛素作用或两者兼有的缺陷引起的高血糖症。它是席卷发达国家和发展中国家的全球流行病。如果紧急不采取任何措施,情况将会恶化。实际上,在全世界范围内的一些研究工作的支持下,寻找具有抗糖尿病潜力的天然产品的需求非常重要,以寻求安全有效的基于植物的抗糖尿病产品。现有文献表明,在某些植物中已经鉴定出几种具有抗糖尿病特性的植物化学物质,其中包括美洲豆科植物。因此测试了卵巢沙门氏菌作为抗糖尿病和降血脂药物候选者的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号